1 "http://www.biaxin.com/pdf/biapi.PDF" 2004
2 Lord SR, "Visual risk factors for falls in older people" 49 : 508-515, 2001
3 Ivers RQ, "Visual impairment and falls in older adults. The Blue Mountains Eye Study." 46 : 58-64, 1998
4 Singh G, "Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis" 18 (18): 188-94, 1991
5 Jarboe JK, "The effect of quinine on outer hair cell shapecompliance and force." 132 : 43- 50, 1999
6 Bosanquet N, "The economics of cancer care in the UK" 5 (5): 568-574, 2004
7 Lemstra AW, "The cholinergic deficiency syndrome and its therapeutic implications" 49 (49): 55-60, 2003
8 Stenklev NC, "The aging ear:an otomicroscopic and tympanometric study" 24 (24): 69-76, 2004
9 Wagstaff LR, "Statin-associated memory loss:analysis of 60 case reports and review of the literature" 23 : 871-880, 2003
10 Doraiswamy PM, "Statin use and hippocampal volumes in elderly subhects at risk for Alzheimer's disease:a pilot observational study" 19 (19): 275-278, 2004
1 "http://www.biaxin.com/pdf/biapi.PDF" 2004
2 Lord SR, "Visual risk factors for falls in older people" 49 : 508-515, 2001
3 Ivers RQ, "Visual impairment and falls in older adults. The Blue Mountains Eye Study." 46 : 58-64, 1998
4 Singh G, "Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis" 18 (18): 188-94, 1991
5 Jarboe JK, "The effect of quinine on outer hair cell shapecompliance and force." 132 : 43- 50, 1999
6 Bosanquet N, "The economics of cancer care in the UK" 5 (5): 568-574, 2004
7 Lemstra AW, "The cholinergic deficiency syndrome and its therapeutic implications" 49 (49): 55-60, 2003
8 Stenklev NC, "The aging ear:an otomicroscopic and tympanometric study" 24 (24): 69-76, 2004
9 Wagstaff LR, "Statin-associated memory loss:analysis of 60 case reports and review of the literature" 23 : 871-880, 2003
10 Doraiswamy PM, "Statin use and hippocampal volumes in elderly subhects at risk for Alzheimer's disease:a pilot observational study" 19 (19): 275-278, 2004
11 Doraiswamy PM, "Statin use and hippocampal volumes in elderly subhects at risk for Alzheimer's disease:a pilot observational study" 19 (19): 275-278, 2004
12 Mann RD, "Sedation with ＂non-sedating＂ antihistamines: four prescription-event monitoring studies in general practice." 320 (320): 1184-1186, 2000
13 Matthews D, "Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus:UKPDS 69" 122 (122): 1631-1640, 2004
14 Nevitt M, "Risk factors for recurrent non-syncopal falls" 261 : 2663-8, 1989
15 Lahiri DK, "Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents" 10 (10): 3111-3119, 2004
16 Muldoon MF, "Randomized trial of the effects of simvastin on cognitive functioning in hypercholesterolemic adults" 117 (117): 823-829, 2004
17 Claessen FA, "Quinine pharmacokinetics:ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria" 3 (3): 482-489, 1998
18 Lord SR, "Physiological factors associated with falls in older community-dwelling women" 42 : 1110-7, 1994
19 Jibson MD, "New atypical antipsychotic medications" 32 : 215-228, 1998
20 Levit, "National health expenditures in 1997: more slow growth" 17 : 99-110, 1998
21 Lord SR, "Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people" 50 : 1760-1766, 2002
22 Hughes CM, "Medication non-adherence in the elderly : how big is the problem?" 21 (21): 793-811, 2004
23 Kirkwood CK, "Management of insomnia" 39 : 688-696, 1999
24 Cote I, "Is adherence to drug treatment correlated with health-related quality of life?" 12 (12): 621-633, 2003
25 Perucca E, "Inhibition of diazepam metabolism by fluvoxamine:a pharmacokinetic study in normal volunteers" 56 (56): 471-6, 1994
26 Raehl CL, "Individualized drug use assessment in the elderly" 22 (22): 1239-1248, 2002
27 Yu BG, "Efficacy and safety of ziprasidone" 11 (11): 89-96, 2001
28 Jung TT, "Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachidonic acid metabolites in perilymph" 493 : 81-7, 1992
29 Schiffman SS, "Effect of psychotropic drugs on taste responses in young and elderly persons" 855 : 732-737, 1998
30 Moore AR, "Drug-induced cognitive impairment in the elderly" 15 : 15-28, 1999
31 Ackerman BH, "Disturbances of taste and smell induced by drugs" 7 (7): 82-96, 1997
32 Ciulla T, "Diabetic retinopathy and diabetic macular edema: pathophysiology,screening, and novel therapies" 26 (26): 2653-2664, 2003
33 Maziarz DM, "Cost considerations in selecting coronary artery revascularization therapy in the elderly" 4 (4): 219-225, 2004
34 Friedman H, "Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys" 103-5, 1991
35 Pappas BA, "Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients" 21 (21): 11-17, 2000
36 Lue AJ, "Chlorpromazine alters outer hair cell electromotility" 125 (125): 71-76, 2001
37 Deguchi K, "Case of ageusia from a variety of causes" 110 (110): 598-601, 1996
38 Landrum MB, "Care following Acute Myocardial Infarction in the Veterans Administration Medical Centers:A Comparison with Medicare" Health Serv Res 39 : 1773-1792, 2004
39 Matz GJ, "Aminoglycoside cochlear ototoxicity" 26 (26): 705-12, 1993
40 Neil-Dwyer G, "ACEinhibitors in hypertension:assessment of taste and smell function in clinical trials" 3 : 169-76, 1989
41 "2002 건강보험 통계연보 제 24호" 국민건강보험공단 발행 801-802, 2004
42 "2002 건강보험 통계연보 제 24호" 국민건강보험공단 발행 154-, 2004
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
ScienceON
eArticle
